Start free trial

Latest Genmab News & Updates

See the latest news and media coverage for Genmab. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Genmab

Biotechnology company developing antibody therapeutics

genmab.com
Headquarters
2500 Valby, Denmark
Company type
Public company
Number of employees
3,100–5,000
Industry
Pharmaceuticals

Last updated

Latest news about Genmab

In short: Genmab posted positive Phase 3 data for Rina-S and epcoritamab, raised 2026 guidance, and reported strong DARZALEX royalties.

Company announcements

Genmab

Genmab announces positive Phase 3 results for epcoritamab with R-CHOP in DLBCL

The combination showed a 51% reduction in progression or death risk compared to standard care alone. Genmab plans to engage regulators regarding these findings.

Unlock all announcements with a

Media coverage

Börse Express

Genmab Stock: Both endpoints met!

The combination reduced the risk of death by 50 percent compared to pembrolizumab alone; discussions with regulatory authorities are planned.

FierceBiotech

ESMO: Genmab posts phase 3 win for Elahere rival, ahead of ‘very interesting’ data from Merus buyout

Genmab may have arrived in Spain with updated data from a pair of phase 2 studies from the main...

Unlock all articles with a

Never miss news about Genmab

Track Genmab and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Genmab competitors & trending companies

Browse news for competitors to Genmab and other trending companies.